GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (AQSE:ORPH) » Definitions » Securities & Investments

hVIVO (AQSE:ORPH) Securities & Investments


View and export this data going back to 2011. Start your Free Trial

What is hVIVO Securities & Investments?

Securities & Investments only applies to banks.


hVIVO Business Description

Industry
Traded in Other Exchanges
Address
40 Bank Street, Floor 24, London, GBR, E14 5NR
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which is involved in the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.